5-fluorouracil-resistant colonic tumors are highly responsive to sodium butyrate/interleukin-2 bitherapy in rats

International Journal of Cancer

Volumn 73, Issue 6, 1997, Pages 924-928

  Cordel, Sandrine ^a   Heymann, Marie Françoise ^a   Boisteau, Olivier ^a   Oliver, Lisa ^a   Le Pendu, Jacques ^a   Grégoire, Marc ^a   Meflah, Khaled ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; FLUOROURACIL; INTERLEUKIN 2; RECOMBINANT PROTEIN; THYMIDINE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; COLON TUMOR; DOSE RESPONSE; DRUG RESISTANCE; FEMALE; IMMUNOLOGY; METABOLISM; MORTALITY; MOUSE; NUDE MOUSE; RAT; RAT STRAIN; SURVIVAL RATE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUTYRIC ACID; BUTYRIC ACIDS; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; INTERLEUKIN-2; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED STRAINS; RECOMBINANT PROTEINS; SURVIVAL RATE; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0031564105     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971210)73:6<924::AID-IJC27>3.0.CO;2-2     Document Type: Article

References (25)

1. ALLEGRA, C.J., New therapeutic strategies for patients with gastrointestinal malignancies using biochemical modulation of fluorouracil. J. Amer. med. Ass., 273, 236-239 (1995).
2. ASCHELE, C., SOBRERO, A., FADERAN, M.A. and BERTINO, J.R., Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res., 52, 1855-1864 (1992).
3. BECK, A., ETIENNE, M.C., CHERADAME, S., FISCHEL, J.L., FORMENTO, P., REN ÉE, N. and MILANO, G., A role of dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Europ. J. Cancer, 30A, 1517-1522 (1994).
4. CAIGNARD, A., MARTIN, M.S., MICHEL, M.F. and MARTIN, F., Interaction between two cellular sub-populations of a rat colonie carcinoma when inoculated to the syngeneic host. Int. J. Cancer. 36, 273-279 (1985).
5. CAO, S., FRANK, C. and RUSTUM, Y.M., Role of fluoropyrimidine schedule and (6R,S) leucovorin dose in a preclinical animal model of colorectal carcinoma. J. nat. Cancer Inst., 88, 430-436 (1996).
6. CARMICHAEL, J., DE GRAFF W.G., GAZDAR, A.F., MINNA, J.D. and MITCHELL J.B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47, 936-942 (1987).
7. CHAUFFERT, B., DIMANCHE-BOITREL, M.T., GENNE, P., PETIT, J.M., ONIER, N. and JEANNIN, J.F., Chimiothérapie expérimentale d'une carcinomatose péritonéale d'origine colique chez le rat. Gastroenterol. clin. biol., 16, 215-219 (1992).
8. CHU, E., KOELLER, D.M., JOHNSTON, P.G., ZINN, S. and ALLEGRA, C.J., Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-γ. Mol. Pharmacol., 43, 527-533 (1992).
9. CONOVER, W.J., Pratical nonparametric statistics, J. Wiley, New-York (1980).
10. HOUGHTON, J.A., RADPARVAR, S., TORRANCE, P.M., WILLIAMS, L.G. and HOUGHTON, P.J., Determination of thymidylate synthase activity in colon tumor tissues after treatment with 5-fluorouracil. Biochem. Pharmacol., 36, 1285-1289 (1987).
11. LESUFFLEUR, T., KORNOWSKI, A., AUGERON, C., DUSSAULX, E., BARBAT, A., LABOISSE, C. and ZWEIBAUM, A., Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation. Int. J. Cancer, 49, 731-737 (1991a).
12. LESUFFLEUR, T., KORNOWSKI, A., LUCCIONI, C., MULERIS, M., BARBAT, A., BEAUMATIN, J., DUSSAULX, E., DUTRILLAUX, B. and ZWEIBAUM, A., Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation. Int. J. Cancer, 49, 721-730 (1991b).
13. MANTEL, N. and HAENSZEL, W., Statistical aspects of the analysis of data from retrospective studies of disease. J. nat. Cancer Inst., 22, 719-748 (1959).
14. MARTIN, F., CAIGNARD, A., JEANNIN, J.F., LECLERC, A. und MARTIN, M., Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int. J. Cancer. 32, 623-627 (1983).
15. MAYER, R.J., Chemotherapy for metastatic coloreclal cancer. Cancer, 70, 1414-1424 (1992).
16. MOERTEL, C.G., Accomplishments in surgical adjuvant therapy for large bowel cancer. Cancer, 70, 1364-1371 (1992).
17. MORAN, R.G. and SCANLON, K.L., Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid. Cancer Res., 51, 4618-4623 (1991).
18. MORAN, R.G., SPEARS, C.P. and HEIDELBERGER, C., Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthetase. Proc. nat. Acad. Sci. (Wash.), 76, 1455-1460 (1979).
19. PERRIN, P., CASSAGNAU, E., BURG, C., PATRY, Y., VAVASSEUR, F., HARB, J., LE PENDU, J., DOUILLARD, J.Y., GALMICHE, J.P., BORNET, F. and MEFLAH, K., An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis. Gastroenterology, 107, 1697-1708 (1994).
20. PETERS, G.J., VAN DER WILT, C.L., VAN TRIEST, B., CODACCI-PISANELLI, G., JOHNSTON, P.G., VAN GROENINGEN C.J. and PINEDO H.M., Thymidylate synthase and drug resistance. Europ. J. Cancer. 31A, 1299-1305 (1995).
21. PETERS, G.J., VAN GROENINGEN, C.J., LAURENSSE, E.J. and PINEDO, H.M., A comparison of 5-fluorouracil metabolism in human coloreclal cancer and colon mucosa. Cancer. 68, 1903-1909 (1991).
22. PIEDBOIS, P., BUYSE, M., RUSTUM, Y., MACHOVER, D., ERLICHMAN, C. and CARLSON, R.W., Modulation of fluorouracil by leucovorin in patients with advanced coloreclal cancer: evidence in terms of response rate. J. clin. Oncol., 10, 896-903 (1992).
23. PIZZORNO, G. and HANDSCHUMACHER, R.E., Effect of clinically modeled regimens on the growth response and development of resistance in human colon carcinoma cell lines. Biochem. Pharmacol., 49, 559-565 (1995).
24. TAYLOR, I., Chemotherapy, radiotherapy and immunotherapy of colorectal neoplasia. Curr. Opinion Gastroenterol., 9, 28-33 (1993).
25. WANG, F.S., ASCHELE, C., SOBRERO, A., CHANG, Y.M. and BERTINO, J.R., Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance. Cancer Res., 53, 3677-3680 (1993).